Published in Circ Res on March 16, 2007
Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol (2009) 3.05
Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol (2009) 2.93
Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. J Vasc Res (2009) 1.78
Homocysteine promotes vascular smooth muscle cell migration by induction of the adipokine resistin. Am J Physiol Cell Physiol (2009) 1.57
Redox signaling, vascular function, and hypertension. Antioxid Redox Signal (2008) 1.52
Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv (2011) 1.52
Angiotensin II upregulates endothelial lipase expression via the NF-kappa B and MAPK signaling pathways. PLoS One (2014) 1.49
Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J Hematol Oncol (2013) 1.42
Kruppel-like Factors (KLFs) in muscle biology. J Mol Cell Cardiol (2007) 1.41
CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration. Br J Pharmacol (2007) 1.32
Fluid flow mechanotransduction in vascular smooth muscle cells and fibroblasts. Ann Biomed Eng (2011) 1.32
Inhibition or ablation of p21-activated kinase (PAK1) disrupts glucose homeostatic mechanisms in vivo. J Biol Chem (2011) 1.28
Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circ Res (2015) 1.27
Hypoxia-inducible factor-1 activation in nonhypoxic conditions: the essential role of mitochondrial-derived reactive oxygen species. Mol Biol Cell (2010) 1.25
The emerging role of the endocannabinoid system in cardiovascular disease. Semin Immunopathol (2009) 1.24
Plexiform lesions in pulmonary arterial hypertension composition, architecture, and microenvironment. Am J Pathol (2011) 1.23
Src-dependent STAT-3-mediated expression of monocyte chemoattractant protein-1 is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration. J Biol Chem (2009) 1.20
Cell biology of embryonic migration. Birth Defects Res C Embryo Today (2008) 1.14
Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway. J Mol Cell Cardiol (2008) 1.03
Vascular remodeling in pulmonary hypertension. J Mol Med (Berl) (2013) 1.02
p130 Crk-associated substrate (CAS) in vascular smooth muscle. J Cardiovasc Pharmacol Ther (2009) 1.01
Vinpocetine suppresses pathological vascular remodeling by inhibiting vascular smooth muscle cell proliferation and migration. J Pharmacol Exp Ther (2012) 0.99
Migration of airway smooth muscle cells. Proc Am Thorac Soc (2008) 0.99
Cyclosporine up-regulates Krüppel-like factor-4 (KLF4) in vascular smooth muscle cells and drives phenotypic modulation in vivo. J Pharmacol Exp Ther (2010) 0.99
Therapeutic angiogenesis: controlled delivery of angiogenic factors. Ther Deliv (2012) 0.97
In vivo therapeutic potential of mesenchymal stromal cells depends on the source and the isolation procedure. Stem Cell Reports (2015) 0.97
Arterial territory-specific phosphorylated retinoblastoma protein species and CDK2 promote differences in the vascular smooth muscle cell response to mitogens. Cell Cycle (2013) 0.96
Activation of the sonic hedgehog signaling controls human pulmonary arterial smooth muscle cell proliferation in response to hypoxia. Biochim Biophys Acta (2010) 0.95
Integrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformation. BMC Cardiovasc Disord (2013) 0.95
Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility. Am J Physiol Cell Physiol (2011) 0.94
Prostaglandin E2-activated Epac promotes neointimal formation of the rat ductus arteriosus by a process distinct from that of cAMP-dependent protein kinase A. J Biol Chem (2008) 0.93
Endothelial nitric oxide synthase inhibits G12/13 and rho-kinase activated by the angiotensin II type-1 receptor: implication in vascular migration. Arterioscler Thromb Vasc Biol (2008) 0.93
IQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury. Am J Physiol Cell Physiol (2013) 0.92
Perivascular cells in blood vessel regeneration. Biotechnol J (2013) 0.91
SWI/SNF chromatin-remodeling complexes in cardiovascular development and disease. Cardiovasc Pathol (2013) 0.91
Differential effects of caldesmon on the intermediate conformational states of polymerizing actin. J Biol Chem (2009) 0.90
Sulforaphane reduces vascular inflammation in mice and prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway. J Nutr Biochem (2014) 0.90
Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IΚBα/NF-κB signaling pathway. J Nutr Biochem (2014) 0.89
Single cell gene expression analysis in injury-induced collective cell migration. Integr Biol (Camb) (2014) 0.87
Therapeutic strategies to combat neointimal hyperplasia in vascular grafts. Expert Rev Cardiovasc Ther (2012) 0.87
Thymosin β4 is not required for embryonic viability or vascular development. Circ Res (2013) 0.86
Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies. Br J Pharmacol (2012) 0.86
Morelloflavone blocks injury-induced neointimal formation by inhibiting vascular smooth muscle cell migration. Biochim Biophys Acta (2008) 0.86
Role of c-Abl tyrosine kinase in smooth muscle cell migration. Am J Physiol Cell Physiol (2014) 0.86
Role of reactive oxygen species and redox in regulating the function of transient receptor potential channels. Antioxid Redox Signal (2011) 0.86
Mechanisms of arterial remodeling: lessons from genetic diseases. Front Genet (2012) 0.85
HCMV pUS28 initiates pro-migratory signaling via activation of Pyk2 kinase. Herpesviridae (2010) 0.85
Role of coronin 1B in PDGF-induced migration of vascular smooth muscle cells. Circ Res (2012) 0.85
Toona sinensis inhibits LPS-induced inflammation and migration in vascular smooth muscle cells via suppression of reactive oxygen species and NF-κB signaling pathway. Oxid Med Cell Longev (2014) 0.85
Slingshot isoform-specific regulation of cofilin-mediated vascular smooth muscle cell migration and neointima formation. Arterioscler Thromb Vasc Biol (2011) 0.84
EBP50 promotes focal adhesion turnover and vascular smooth muscle cells migration. J Mol Cell Cardiol (2012) 0.83
Functional regulation of ClC-3 in the migration of vascular smooth muscle cells. Hypertension (2012) 0.83
Biphasic responses of human vascular smooth muscle cells to magnesium ion. J Biomed Mater Res A (2015) 0.82
Nogo-B regulates migration and contraction of airway smooth muscle cells by decreasing ARPC 2/3 and increasing MYL-9 expression. Respir Res (2011) 0.82
3,4-Di-O-Caffeoylquinic Acid Inhibits Angiotensin-II-Induced Vascular Smooth Muscle Cell Proliferation and Migration by Downregulating the JNK and PI3K/Akt Signaling Pathways. Evid Based Complement Alternat Med (2011) 0.82
p21-activated kinase 1 participates in vascular remodeling in vitro and in vivo. Hypertension (2009) 0.82
Resveratrol induces p53 and suppresses myocardin-mediated vascular smooth muscle cell differentiation. Toxicol Lett (2010) 0.81
Collagen inhibitory peptide R1R2 mediates vascular remodeling by decreasing inflammation and smooth muscle cell activation. PLoS One (2015) 0.81
Resveratrol inhibits migration and Rac1 activation in EGF- but not PDGF-activated vascular smooth muscle cells. Mol Nutr Food Res (2011) 0.81
ZIPK is critical for the motility and contractility of VSMCs through the regulation of nonmuscle myosin II isoforms. Am J Physiol Heart Circ Physiol (2014) 0.80
The Protective Effect of Bee Venom on Fibrosis Causing Inflammatory Diseases. Toxins (Basel) (2015) 0.80
The LIM-only protein FHL2 reduces vascular lesion formation involving inhibition of proliferation and migration of smooth muscle cells. PLoS One (2014) 0.80
The cAMP-producing agonist beraprost inhibits human vascular smooth muscle cell migration via exchange protein directly activated by cAMP. Cardiovasc Res (2015) 0.79
Rear actomyosin contractility-driven directional cell migration in three-dimensional matrices: a mechano-chemical coupling mechanism. J R Soc Interface (2014) 0.79
High resolution surface plasmon resonance imaging for single cells. BMC Cell Biol (2014) 0.79
Novel role of copper transport protein antioxidant-1 in neointimal formation after vascular injury. Arterioscler Thromb Vasc Biol (2013) 0.79
Evodiamine Attenuates PDGF-BB-Induced Migration of Rat Vascular Smooth Muscle Cells through Activating PPARγ. Int J Mol Sci (2015) 0.79
A cautionary tale for autologous vascular tissue engineering: impact of human demographics on the ability of adipose-derived mesenchymal stem cells to recruit and differentiate into smooth muscle cells. Tissue Eng Part A (2014) 0.79
A gel-free approach in vascular smooth muscle cell proteome: perspectives for a better insight into activation. Proteome Sci (2010) 0.79
Matricellular protein Cyr61 bridges lysophosphatidic acid and integrin pathways leading to cell migration. J Biol Chem (2013) 0.79
Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1/Cyr61. Am J Physiol Cell Physiol (2016) 0.78
Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanisms. Int J Biochem Cell Biol (2013) 0.78
Berberine suppresses in vitro migration of human aortic smooth muscle cells through the inhibitions of MMP-2/9, u-PA, AP-1, and NF-κB. BMB Rep (2014) 0.78
Resident phenotypically modulated vascular smooth muscle cells in healthy human arteries. J Cell Mol Med (2012) 0.78
Ribozyme-mediated gene knock down strategy to dissect the consequences of PDGF stimulation in vascular smooth muscle cells. BMC Res Notes (2012) 0.78
LDL-induced impairment of human vascular smooth muscle cells repair function is reversed by HMG-CoA reductase inhibition. PLoS One (2012) 0.77
Urokinase requires NAD(P)H oxidase to transactivate the epidermal growth factor receptor. Surgery (2012) 0.77
Sparstolonin B suppresses rat vascular smooth muscle cell proliferation, migration, inflammatory response and lipid accumulation. Vascul Pharmacol (2015) 0.77
Lysophosphatidic acid induces integrin activation in vascular smooth muscle and alters arteriolar myogenic vasoconstriction. Front Physiol (2014) 0.77
Arsenic alters vascular smooth muscle cell focal adhesion complexes leading to activation of FAK-src mediated pathways. Toxicol Appl Pharmacol (2008) 0.77
Calcium channel blockers, more than diuretics, enhance vascular protective effects of angiotensin receptor blockers in salt-loaded hypertensive rats. PLoS One (2012) 0.77
ROCK inhibition prevents fetal serum-induced alteration in structure and function of organ-cultured mesenteric artery. J Muscle Res Cell Motil (2011) 0.77
Increasing our IQ of vascular smooth muscle cell migration with IQGAP1. Focus on "IQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury". Am J Physiol Cell Physiol (2013) 0.77
PLCβ3 mediates cortactin interaction with WAVE2 in MCP1-induced actin polymerization and cell migration. Mol Biol Cell (2015) 0.77
Signaling of the p21-activated kinase (PAK1) coordinates insulin-stimulated actin remodeling and glucose uptake in skeletal muscle cells. Biochem Pharmacol (2014) 0.77
Vascular smooth muscle cell motility is mediated by a physical and functional interaction of Ca2+/calmodulin-dependent protein kinase IIδ2 and Fyn. J Biol Chem (2013) 0.76
Local CXCR4 Upregulation in the Injured Arterial Wall Contributes to Intimal Hyperplasia. Stem Cells (2016) 0.76
The role of reactive oxygen species in microvascular remodeling. Int J Mol Sci (2014) 0.76
Caldesmon as a therapeutic target for proliferative vascular diseases. Mini Rev Med Chem (2008) 0.76
TonEBP/NFAT5 regulates ACTBL2 expression in biomechanically activated vascular smooth muscle cells. Front Physiol (2014) 0.76
Biophysical induction of vascular smooth muscle cell podosomes. PLoS One (2015) 0.76
Annexin II-dependent actin remodelling evoked by hydrogen peroxide requires the metalloproteinase/sphingolipid pathway. Redox Biol (2014) 0.76
Bo-Gan-Whan regulates proliferation and migration of vascular smooth muscle cells. BMC Complement Altern Med (2016) 0.75
New Amniotic Membrane Based Biocomposite for Future Application in Reconstructive Urology. PLoS One (2016) 0.75
Endothelial lipase is upregulated by interleukin-6 partly via the p38 MAPK and p65 NF-κB signaling pathways. Mol Med Rep (2016) 0.75
Transcriptional profiling of human smooth muscle cells infected with gingipain and fimbriae mutants of Porphyromonas gingivalis. Sci Rep (2016) 0.75
Src tyrosine kinase mediates platelet-derived growth factor BB-induced and redox-dependent migration in metanephric mesenchymal cells. Am J Physiol Renal Physiol (2013) 0.75
Biomimetic-engineered poly (ethylene glycol) hydrogel for smooth muscle cell migration. Tissue Eng Part A (2014) 0.75
Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway. PLoS One (2017) 0.75